Last reviewed · How we verify
NCT02129218
Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer
NA trial testing questionnaire administration in Stage I Colon Cancer in 18 participants. Completed in 10 July 2018.
14 June 2018
Quick facts
| Lead sponsor | Case Comprehensive Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 18 |
| Start date | 16 February 2015 |
| Primary completion | 14 June 2018 |
| Estimated completion | 10 July 2018 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- questionnaire administration
- laboratory biomarker analysis — full drug profile →
- Standard Dietary Intervention
- Intensified Dietary Intervention
- Low glycemic load
- Medium Glycemic Load
Conditions studied
- Stage I Colon Cancer — all drugs for Stage I Colon Cancer →
- Stage II Colon Cancer — all drugs for Stage II Colon Cancer →
- Stage III Colon Cancer — all drugs for Stage III Colon Cancer →
- Stage I Rectal Cancer — all drugs for Stage I Rectal Cancer →
Sponsor
Case Comprehensive Cancer Center — full company profile →
Who can join
18 and older, any sex, with Stage I Colon Cancer or Stage II Colon Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot clinical trial studies the feasibility of a low glycemic load diet in patients with stage I-III colon cancer. A low glycemic load diet includes foods that have low scores on the glycemic index. The glycemic index is a scale that measures how much a certain carbohydrate causes a person's blood sugar to rise. A low glycemic load diet may help decrease the chance of cancer coming back and improve the survival in patients with colon cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Trial watch: dietary interventions for cancer therapy.
Lévesque S, Pol JG, Ferrere G, Galluzzi L, et al · · 2019 · cited 48× · PMID 31143510 · DOI 10.1080/2162402x.2019.1591878
Verify or expand the search:
- PubMed search for NCT02129218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of questionnaire administration
Trials testing the same drug.
- NCT03651492 — Effects of Nocturnal Hypertension on Sleep Quality in Renal Transplant Recipients · unknown
- NCT02059499 — Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions · Phase 3 · completed
- NCT02288416 — Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening · NA · completed
- NCT02217709 — Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer · Phase 2 · completed
- NCT02235051 — Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors · NA · completed
Other recruiting trials for Stage I Colon Cancer
Currently open trials in the same condition.
- NCT05870800 — Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER · Phase 2 · recruiting
Other Case Comprehensive Cancer Center trials
Trials by the same sponsor.
- NCT06811454 — Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) · NA · not yet recruiting
- NCT07167056 — Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer · NA · recruiting
- NCT07084779 — Investigation of Impact of AI on Prostate Cancer Workflow · NA · recruiting
- NCT06904482 — Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood · Phase 2 · recruiting
- NCT07044362 — Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02129218 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Case Comprehensive Cancer Center
- Last refreshed: 20 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02129218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing